Medical device company
Hylomorph has raised €13M across 3 funding rounds from 11 investors, most recently a Series B round in Sep 2023. Based in Zurich, Switzerland; founded 2014; active in Healthtech. Data as of 7 Aug 2026.
Timing: overdue vs cohort gap · momentum flat. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage |
|---|
| Amount |
|---|
| Investors |
|---|
| 2023-09-05 | Series B | €4.7M | Business Angels,EFI Lake Geneva Ventures,Excellis Holding,Interconsult,Italian Investors Club,Start Angels Network Switzerland+2 more | View deal → |
| 2021-12-05 | Series B | €5.0M | EFI Lake Geneva Ventures,Geneva Smart Invest (GSI),Start Angels Network,Verve Ventures,Zürcher Kantonalbank | View deal → |
| 2018-08-30 | Series A | €2.8M | Fongit SEED Invest | View deal → |
